sildenafil teva pharma 20 mg apvalkotās tabletes
teva pharma b.v., netherlands - sildenafils - apvalkotā tablete - 20 mg
cazitel plus
chanelle pharmaceuticals manufacturing ltd., Īrija - prazikvantels, pirantela embonate, febantels - tabletes - suņi
nucala
glaxosmithkline trading services - mepolizumabs - astma - zāles obstruktīvu elpceļu slimību, - severe eosinophilic asthmanucala is indicated as an add-on treatment for severe refractory eosinophilic asthma in adults, adolescents and children aged 6 years and older. chronic rhinosinusitis with nasal polyps (crswnp)nucala is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adult patients with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate control. eosinophilic granulomatosis with polyangiitis (egpa)nucala is indicated as an add-on treatment for patients aged 6 years and older with relapsing-remitting or refractory eosinophilic granulomatosis with polyangiitis (egpa). hypereosinophilic syndrome (hes)nucala is indicated as an add-on treatment for adult patients with inadequately controlled hypereosinophilic syndrome without an identifiable non-haematologic secondary cause.
nilodux 30 mg zarnās šķīstošās cietās kapsulas
pharmaswiss ceska republika s.r.o., czech republic - duloksetīns - zarnās šķīstošās cietās kapsulas - 30 mg
nilodux 60 mg zarnās šķīstošās cietās kapsulas
pharmaswiss ceska republika s.r.o., czech republic - duloksetīns - zarnās šķīstošās cietās kapsulas - 60 mg
irsamla 5 mg apvalkotās tabletes
egis pharmaceuticals plc, hungary - vortioksetīns - apvalkotā tablete - 5 mg
irsamla 10 mg apvalkotās tabletes
egis pharmaceuticals plc, hungary - vortioksetīns - apvalkotā tablete - 10 mg
irsamla 15 mg apvalkotās tabletes
egis pharmaceuticals plc, hungary - vortioksetīns - apvalkotā tablete - 15 mg
irsamla 20 mg apvalkotās tabletes
egis pharmaceuticals plc, hungary - vortioksetīns - apvalkotā tablete - 20 mg
nulibry
tmc pharma (eu) limited - fosdenopterin hydrobromide dihydrate - metal metabolism, inborn errors - citas gremošanas trakta un metabolisma produkti, - nulibry is indicated for the treatment of patients with molybdenum cofactor deficiency (mocd) type a.